GoodRx Holdings (GDRX) Preferred Stock Liabilities (2019 - 2020)

GoodRx Holdings (GDRX) reported Preferred Stock Liabilities of $737.0 million for Q2 2020, little changed sequentially from $737.0 million in Q1 2020.

GoodRx Holdings (GDRX) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

GoodRx Holdings (GDRX) has 2 years of Preferred Stock Liabilities data on file, last reported at $737.0 million in Q2 2020.

  • For the quarter ending Q2 2020, Preferred Stock Liabilities changed N/A year-over-year to $737.0 million; the trailing twelve-month figure through Jun 2020 stood at $737.0 million (changed N/A YoY), and the FY2019 full-year result was $737.0 million, changed 0.0% from the prior year.
  • Preferred Stock Liabilities was little changed at $737.0 million in Q2 2020, from $737.0 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $737.0 million in Q3 2019 to a low of $737.0 million in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Veeva Systems 31.68 Bn 24.36 Bn 662.02 Mn -
2 BrightSpring Health Services 14.66 Bn 13.76 Bn 482.22 Mn -
3 Healthequity 8.28 Bn 8.02 Bn 256.31 Mn -
4 Hinge Health 5.88 Bn 5.56 Bn 154.23 Mn 199.87 Mn
5 10x Genomics 5.81 Bn 5.27 Bn 106.18 Mn -
6 MiniMed 4.51 Bn 4.21 Bn 480.00 Mn -
7 Waystar Holding 4.45 Bn 4.39 Bn 216.84 Mn -
8 Doximity 3.94 Bn 3.19 Bn 125.97 Mn -
9 Privia Health 3.17 Bn 2.75 Bn - -
10 GoodRx Holdings 1.02 Bn 784.18 Mn 173.85 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2020 737.01 Mn
Mar 31, 2020 737.01 Mn
Dec 31, 2019 737.01 Mn
Sep 30, 2019 737.01 Mn